Ana Cvetanović
- Co-authors
- Nikola ŽivkovićMiloš KostićIvana StojanovićGoran MarjanovićVladimir SavićMiodrag ČolićSlobodan VojinovićTanja Džopalić
- Topics
- HER2/EGFR in Cancer Research (9 papers)Breast Cancer Treatment Studies (9 papers)Cancer Treatment and Pharmacology (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaAnnals of OncologyJournal of Neuroimmunology
- Partner nations
- SerbiaUnited KingdomFinland
In The Last Decade
Ana Cvetanović
32 papers receiving 329 citations
Peers
Comparison fields: 5 of 74
- Immunology 110
- Pathology and Forensic Medicine 98
- Oncology 85
- Molecular Biology 71
- Neurology 59
Countries citing papers authored by Ana Cvetanović
This map shows the geographic impact of Ana Cvetanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Cvetanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Cvetanović more than expected).
Fields of papers citing papers by Ana Cvetanović
This network shows the impact of papers produced by Ana Cvetanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Cvetanović. The network helps show where Ana Cvetanović may publish in the future.
Co-authorship network of co-authors of Ana Cvetanović
This figure shows the co-authorship network connecting the top 25 collaborators of Ana Cvetanović. A scholar is included among the top collaborators of Ana Cvetanović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Cvetanović. Ana Cvetanović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | Interlaboratory concordance in HER2 testing: Results of a Serbian ring-study. | 4 |
| 9 | 3 | |
| 10 | 40 | |
| 11 | Current and future targets and therapies in metastatic colorectal cancer. | 14 |
| 12 | 6 | |
| 13 | Do we really know how to overcome trastuzumab resistance in hormone sensitive metastatic breast cancer? | 1 |
| 14 | 0 | |
| 15 | 18 | |
| 16 | 0 | |
| 17 | 43 | |
| 18 | 7 | |
| 19 | 0 | |
| 20 | 27 |
About Ana Cvetanović
Ana Cvetanović is a scholar working on Oncology, Cancer Research and Hepatology, having authored 40 papers that have together received 329 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Biological Psychiatry (21 citations), Neurology (59 citations) and Pathology and Forensic Medicine (98 citations). Ana Cvetanović has collaborated with scholars based in Serbia, United Kingdom and Finland. Frequent co-authors include Nikola Živković, Miloš Kostić, Ivana Stojanović, Goran Marjanović, Vladimir Savić, Miodrag Čolić, Slobodan Vojinović, Tanja Džopalić, Slavoljub Živanović and Lazar Popović. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Journal of Neuroimmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.